ENDO 2025 Abstract
MON-547 Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: A Systematic Review And Meta-analysis of Randomized Controlled Trials
ReviewInterventions
The paper
Georgetown University; Mansoura University
ENDO 2025 Abstract, 22 Oct 2025, CC BY-NC-ND
Presented at ENDO 2025